More importantly, a high level of DOCK1 expression is associated with poor prognosis in patients with basal-like breast cancer and ovarian cancer [20,21], which suggests an operative machinery by DOCK1 in the tumorigenesis and metastasis of TNBC. Here, DOCK1 is linked to ovarian cancer.